RT Journal Article
SR Electronic
T1 Investigating risks for human colonisation with extended spectrum beta-lactamase producing <em>E. coli</em> and <em>K. pneumoniae</em> in Malawian households: a one health longitudinal cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.08.16.22278508
DO 10.1101/2022.08.16.22278508
A1 Cocker, Derek
A1 Chidziwisano, Kondwani
A1 Mphasa, Madalitso
A1 Mwapasa, Taonga
A1 Lewis, Joseph M.
A1 Rowlingson, Barry
A1 Sammarro, Melodie
A1 Bakali, Winnie
A1 Salifu, Chifundo
A1 Zuza, Allan
A1 Charles, Mary
A1 Mandula, Tamandani
A1 Maiden, Victor
A1 Amos, Stevie
A1 Jacob, Shevin T
A1 Kajumbula, Henry
A1 Mugisha, Lawrence
A1 Musoke, David
A1 Byrne, Rachael
A1 Edwards, Thomas
A1 Lester, Rebecca
A1 Elviss, Nicola
A1 Roberts, Adam
A1 Singer, Andrew C
A1 Jewell, Christopher
A1 Morse, Tracy
A1 Feasey, Nicholas A
YR 2022
UL http://medrxiv.org/content/early/2022/08/21/2022.08.16.22278508.abstract
AB Background Low- and middle-income countries (LMICs) have high morbidity and mortality from drug-resistant infections, especially from enteric bacteria such as Escherichia coli. LMICs have varying infrastructure and services in the community to separate people from human and animal waste, creating risks for ESBL-Enterobacterales (ESBL-E) transmission. Limited data exist from Southern Africa on the prevalence of ESBL-E the community.Methods and findings In this longitudinal cohort study we took a one-health approach to investigating prevalence and distribution of ESBL-E in urban, peri-urban and rural Malawian households between May 2018 and October 2020. We described human health, antibiotic usage (ABU), health seeking behaviour, structural and behavioural environmental health practices, and animal husbandry at these households. In parallel, human and animal stool and diverse environmental samples were collected and cultured to identify presence of ESBL E. coli and ESBL K. pneumoniae. Univariable and multivariable analysis was performed to determine associations with human ESBL-E colonisation.We recruited 300 households, totalling 841 visits, and a paucity of environmental health infrastructure and materials for safe sanitation was noted across all sites. In total, 11,975 samples were cultured and ESBL-E were isolated from 41.8% (n=1190) of human stool and 29.8% (n=290) of animal stool samples. Animal species with particularly high rates of ESBL-E colonisation included pigs (56.8%, n=21) poultry (32.5%, n=148) and dogs (58.8% n= 30). ESBL-E were isolated from 66.2% (n=339) of river water samples and 46.0% (n=138) of drain samples. Urban areas had greater ESBL-E contamination of food, household surfaces, floors and the external environment, alongside the highest rates of ESBL-E colonisation in humans (47.1%, n=384) and animals (55.1%, n=65). Multivariable models illustrated that human ESBL E. coli colonisation was associated with the wet season (aOR = 1.66, 95%CrI: 1.38-2.00), living in urban areas (aOR = 2.01, 95%CrI: 1.26-3.24), advanced age (aOR = 1.14, 95%CrI: 1.05-1.24) and in households where animals were observed interacting with food (aOR = 1.62, 95%CrI: 1.17-2.28) or kept inside (aOR = 1.58, 95%CrI: 1.00-2.43). Human ESBL K. pneumoniae colonisation was also associated with the wet season (aOR = 2.23, 95%CrI: 1.63-2.76.Conclusion We identified extremely high levels of ESBL-E colonisation in humans and animals and contamination of the environment in Southern Malawi. Urbanisation and season are key risks for ESBL-E colonisation, perhaps reflecting environmental contamination as toilets overflow in high population density areas in heavy rains in the wet season. Without adequate efforts to improve environmental health, ESBL transmission is likely to persist in this setting.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Bill and Melinda Gates foundation and Wellcome Trust.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committees of the Liverpool School of Tropical Medicine (LSTM), UK (REC, #18-090) and College of Medicine, Malawi (#P.11/18/2541) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript